Clinical Trials Browser

Terminated × OTHER × Leukemia, Plasma Cell × Clear all

NCT00615589 2016-04-04

Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen

Phase 2 Terminated

22 enrolled 9 charts

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma, Recurrence